Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Targeted Cancer Therapies & Biofluid Biopsies

Targeted Cancer Therapies & Biofluid Biopsies

Date: Thursday, 25 May 2017 - Friday, 26 May 2017
Location: Bengaluru


After the last year's event on Biofluid Biopsies in Bengaluru, SELECTBIO brings to you an enhanced version of the same event on Cancer Diagnosis and Treatment. The event  has been entitled "Targeted Cancer Therapies and Biofluid Biopsies". 

The event aims to bring together different fraternities of scientists who are working towards Cancer diagnosis and selective treatment of cancer. Targetted cancer therapies include Cancer immunotherapy, Hormone therapy, ADC, Apoptosis inducers, Angiogenesis inhibitors, ST inhibitors and Gene therapy. The session on Biofluid biopsies will focus primarily on blood-based molecular biomarkers such as Circulating Tumor DNA (ctDNA) for developing biological fluid-based biopsies as well as Circulating Tumor Cells (CTCs) and Protein-based Circulating Biomarkers. 

This event is beneficial for the Scientists who are working or planning to work in the area of extracellular nucleic acids, extracellular vesicles, circulating cell free DNA, microRNA, Liquid biopsies etc. 

This conference will provide scientists and researchers with most up-to-date information & emerging trends in the area of Cancer Therapies and Biofluid Biopsies. Open discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the Targetted Cancer Therapies and Circulating Biomarkers Landscape, especially in the Indian context.

Venue and Dates: Le Méridien Bangalore Hotel, Bengaluru, India on May 25-26, 2017

Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 31 March 2017

Agenda Topics

  • Antibodies and Antibody Drug Conjugates for Cancer Therapeutics
  • Cancer Immunotherapy
  • Circulating Cells & Nucleic Acids as Biomarkers
    • CTCs, cfDNA, exRNA, EVs
  • Current Targetted Cancer Therapies
    • Angiogenesis Inhibitors
    • Apoptosis Inducers
    • Hormone Therapies
    • Signal Transduction Inhibitors
  • Emerging Technology Platforms for Developing Biofluid-based Biopsies
  • Gene Therapy and Cancer Vaccines
  • Targetted Cancer Drug Delivery Systems

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Invited Confirmed Speakers

Aditi Chatterjee, Faculty Scientist, Institute of Bioinformatics
Sunil J Advani, Associate Professor & Associate Division Director Clinical and Translational Research, University of California, San Diego
Xinghua Victor Pan, Research Scientist, Yale University
Olivier Pardo, Team Leader, Imperial College London
Winston Patrick Kuo, President, Predicine Holdings Ltd
Rajiv Raja, Director, MedImmune AstraZeneca

Invited Speakers

Charles Coombes, Clinical Professor, Imperial College London
Said Dermime, Senior Scientist & Director of Translational Cancer Research Facility, National Centre for Cancer Care and Research, HMC
Morganna Freeman, Associate Director, The Angeles Clinic and Research Institute
Abid Hamid Dar, Sr. Scientist, CSIR - Indian Institute of Integrative Medicine
Fred Hirsch, Professor, University of Colorado Cancer Center
Fumito Ito , Assistant Professor, Roswell Park Cancer Institute
Wen Jiang, Professor, Cardiff University
Shyamala Maheswaran, Associate Professor/Principal Investigator, Harvard Medical School
Marek Malecki, President, Phoenix Biomolecular Engineering Foundation
Abdelwahab Omri, Professor, Laurentian University
Barbara Seliger, Professor, Martin Luther University Halle-Wittenberg
Shou-Ching Tang, Professor, Augusta University
Alain Thierry, Research Director, INSERM
Meghna Trivedi, Associate Professor, University of Houston College of Pharmacy
Kiran Velpula, Assistant professor, University of Illinois College of Medicine at Peoria
Timothy Yap, Clinician Scientist and Consultant Medical Oncologist, The Institute of Cancer Research
Huang-Ge Zhang, Professor, University of Louisville

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Agenda is not currently available
Add to Calendar ▼2017-05-25 00:00:002017-05-26 00:00:00Europe/LondonTargeted Cancer Therapies and Biofluid BiopsiesTargeted Cancer Therapies and Biofluid Biopsies in